<DOC>
	<DOCNO>NCT00594100</DOCNO>
	<brief_summary>To compare 30-day safety efficacy GORE Flow Reversal System use approve carotid stent Objective Performance Criterion derive distal embolic protection study .</brief_summary>
	<brief_title>GORE Embolic Protection With Reverse Flow</brief_title>
	<detailed_description>The GORE Flow Reversal System , manufacture W. L. Gore &amp; Associates , Inc. , develop proximal occlusion device reverse flow blood carotid artery . It design achieve embolic protection prior cross lesion majority case order minimize possibility adverse event occurrence . The objective study ass safety effectiveness GORE Flow Reversal System use provide embolic protection Carotid Artery Stent ( CAS ) procedure . Subjects diagnose carotid stenosis require revascularization high risk adverse event CEA eligible participate .</detailed_description>
	<mesh_term>Carotid Stenosis</mesh_term>
	<criteria>Carotid stenosis require revascularization indicate either symptomatic status , carotid stenosis ≥ 50 % OR asymptomatic status carotid stenosis ≥ 80 % Target lesion locate one following : ( ) internal carotid artery ( ICA ) ( b ) bifurcation ( c ) common carotid artery ( CCA ) proximal bifurcation At Anatomic risk adverse event CEA ( e.g . restenosis prior CEA ) OR Comorbid risk adverse event CEA ( e.g. , unstable angina ECG change ) Recent surgical procedure within 30 day stent procedure Uncontrolled sensitivity contrast medium Renal Insufficiency Recent evolving , acute stroke within 21 day study evaluation Myocardial infarction within 72 hour prior stent procedure History prior major ipsilateral stroke residual neurological deficit likely confound neurological assessment ( e.g. , NIHSS ) Neurological deficit due stroke likely confound neurological assessment ( e.g. , NIHSS ) Angiographic Isolated ipsilateral hemisphere lead subject intolerance reverse flow Total occlusion ipsilateral carotid artery Preexisting stent ipsilateral carotid artery OR contralateral carotid artery extend aortic arch Presence filling defect , thrombus , occlusion `` string sign '' target vessel Severe lesion calcification restrict stent deployment Carotid stenosis locate distal target stenosis severe target stenosis &gt; 50 % stenosis CCA proximal target vessel Known mobile plaque aortic arch</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>carotid artery stenosis</keyword>
	<keyword>embolic protection device</keyword>
	<keyword>GORE Neuro Protection System</keyword>
	<keyword>GORE Flow Reversal System</keyword>
	<keyword>reverse flow</keyword>
	<keyword>proximal occlusion device</keyword>
	<keyword>GNPS</keyword>
	<keyword>Parodi</keyword>
	<keyword>EMPiRE</keyword>
	<keyword>distal embolization</keyword>
	<keyword>minimize risk CAS</keyword>
	<keyword>PAES</keyword>
</DOC>